Regenerative Medical Technology (RMTG) Depreciation & Amortization (IS) (2020 - 2025)
Historic Depreciation & Amortization (IS) for Regenerative Medical Technology (RMTG) over the last 4 years, with Q3 2025 value amounting to $76078.0.
- Regenerative Medical Technology's Depreciation & Amortization (IS) fell 1435.36% to $76078.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $154912.0, marking a year-over-year decrease of 5513.74%. This contributed to the annual value of $220559.0 for FY2024, which is 2887.53% down from last year.
- Regenerative Medical Technology's Depreciation & Amortization (IS) amounted to $76078.0 in Q3 2025, which was down 1435.36% from $54832.0 recorded in Q2 2025.
- Regenerative Medical Technology's 5-year Depreciation & Amortization (IS) high stood at $98667.0 for Q3 2023, and its period low was -$27812.0 during Q4 2024.
- Over the past 3 years, Regenerative Medical Technology's median Depreciation & Amortization (IS) value was $76078.0 (recorded in 2025), while the average stood at $64853.2.
- Examining YoY changes over the last 5 years, Regenerative Medical Technology's Depreciation & Amortization (IS) showed a top increase of 4336.24% in 2024 and a maximum decrease of 12869.23% in 2024.
- Quarter analysis of 3 years shows Regenerative Medical Technology's Depreciation & Amortization (IS) stood at $96932.0 in 2023, then plummeted by 128.69% to -$27812.0 in 2024, then skyrocketed by 373.54% to $76078.0 in 2025.
- Its Depreciation & Amortization (IS) was $76078.0 in Q3 2025, compared to $54832.0 in Q2 2025 and $51814.0 in Q1 2025.